Differences between human plasma and serum metabolite profiles.
Yu Z, Kastenmüller G, He Y, Belcredi P, Möller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-Sattler R
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient gender, smoking status, and a diagnosis of type 2 diabetes as well as blood component analyzed (EDTA plasma versus serum) on the concentrations of 122 metabolites. Specimens were drawn into either serum or EDTA plasma gel tubes, and plasma and serum were processed and frozen at -80 degrees C within 30-60 min of collection. Metabolic analysis was performed using the AbsoluteIDQ kit p150 and flow injection analysis mass spectrometry (FIA-MS).
Summary of Findings
The concentrations of 122 metabolites showed strong correlations with previous results when analyses were repeated for both plasma (r=0.83) and serum specimens (r=0.80), but the reproducibility was significantly higher in plasma specimens (p=0.01). The concentrations of 85% of the 122 metabolites were significantly higher in serum than in plasma, but an overall strong correlation between the two types of specimens was observed (r=0.81). A greater number of metabolites were found to be differentially expressed between patients with type 2 diabetes and those without, males versus females, and smokers versus non-smokers when serum was analyzed rather than plasma.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
Diabetes Type 2Not specifiedPlatforms
LipidLC-MS or LC-MS/MSSmall moleculeLC-MS or LC-MS/MSCarbohydrateLC-MS or LC-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition No type 2 diabetesType 2 diabetesPreaquisition Other drugs Non-smokerSmokerPreaquisition Patient gender FemaleMaleBiospecimen Aliquots and Components Blood and blood products PlasmaSerum